| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_942c901eb2f4538fffee3c52801b11c6 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-063
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-38 |
| filingDate |
1994-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6db78c5f0dc11664216360a5b61d96c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abe32eba8d943dd9e05b6e99b31391dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52f6529ca18d660f6ec9c7ef42a0dac2 |
| publicationDate |
1995-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H0748279-A |
| titleOfInvention |
Treatment of acquired immunodeficiency syndrome |
| abstract |
(57) [Summary] [Objective] The present invention provides a method for treating AIDS. The method comprises administering a therapeutically effective amount of an antiretroviral agent and a therapeutically effective amount of an intracellular glutathione stimulant to an HIV positive patient. Compositions In a preferred embodiment, the antiretroviral agent comprises AZT. In one embodiment, the composition for stimulating intracellular glutathione levels comprises L-2- Includes oxothiazolidine-4-carboxylate. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2001511770-A |
| priorityDate |
1993-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |